A variety of studies have been performed to establish objective biomarkers of the disease, including positron emission tomography (PET) molecular imaging and neuro-functional imaging using magnetic resonance imaging (MRI) and magnetoencephalogram (MEG)
(July 2009)
GHK-Cu acts as a signaling molecule that influences how skin cells behave its associated with stimulating collagen and elastin production, supporting tissue remodeling, and exhibiting antioxidant and anti-inflammatory activity at the cellular level
Clinical studies support its efficacy in improving liver function, insulin resistance, and obesity-related parameters in NAFLD patients [86,87,88]
In addition to , and cells in the pancreas, the receptor has been found in a variety of other tissues, including the intestine, stomach, lungs, heart, kidneys and several regions of the central nervous system (Mller et al., 2019)